Ann Woolley @AnnWoolleyMD X Profile

Ann Woolley

@AnnWoolleyMD

Followers

1K

Following

6K

Media

4

Statuses

255

Infectious disease physician, with a focus on transplant, hepatitis, and cardiac infections @BrighamWomens @harvardmed

Boston, MA

Joined April 2013

Don't wanna be here? Send us removal request.

Infectious Diseases Community of Practice - AST

@AST_IDCOP

1 year

📢📢Trainee poster! ID fellow @MGHBWHIDFellows @bwh_id Dr. Alisse Hannaford @AlisseHannaford presenting on RSV vaccination responses in SOT patients at #ATC2024Philly @AST_IDCOP @AST_info @AnnWoolleyMD @Dr_AmyKacin Congrats on being a poster winner!!

0

5

39

Cesar G. Berto, MD

@CesarGBerto

2 years

Excited to present a case for Clinical Grand Rounds at @ESCMID Interesting cases & teaching points from all around the world 🌎

0

5

38

Ann Woolley

@AnnWoolleyMD

2 years

Excellent and thought provoking talk on the challenges associated with bacterial donor derived infections by @mularoni So nice to chair this session with you! @ECCMID

Alessandra Mularoni

@mularoni

2 years

The challenge of Donor Derived infections @AnnWoolleyMD you did a great job!

0

4

17

Carol Garcia-Vidal

@c_garciavidal

2 years

IMPORTANT CONCLUSIONS! @mhdezmeneses @hospitalclinic @idibaps #ESCMIDGlobal2024

0

5

11

Michael Ison, MD MS

@MichaelGIsonMD

2 years

Master class in MDROs - risks, prevention and management in SOT BY Maddalena Giannella @ECCMID @ESCMID

3

14

49

Anna Apostolopoulou, MD

@AnnaApostolopo3

2 years

If at #ECCMID24, feel free to stop by my poster (Sector B/Row 23) today at noon to discuss the effect of immune checkpoint inhibitors on neutrophil function against C.albicans

3

4

60

Erika Kampouri

@ErikaKampouri

2 years

Important work by txid ⭐️ @JessicaLittleMD @ESCMID infection density increases after bsAb therapy, more opportunistic & life-threatening infections! Come chat p3777!

0

2

23

Eileen Maziarz

@EileenMaziarz

2 years

@RicardoLaHozMD conceptual framework for consideration of #LTx donors with resp viral infection. #HowLongToWait - a critically important ? for 🫁transplant programs. Superb talk! @ISHLT2024 @UTSWInfDis

1

5

16

Ricardo M. La Hoz

@RicardoLaHozMD

2 years

Antimicrobial management of LVAD infections by @StephaniePouch! @ISHLT #ISHLT2024

1

2

36

camwolfe

@camwolfe

2 years

NOTHING better than seeing a prior fellow becoming an absolute international rockstar!! Well done @emilymeich - beautifully presented study on why presatovir didn’t help RSV in lung transplants. @ISHLT @DukeAdultID

1

7

53

Ricardo M. La Hoz

@RicardoLaHozMD

2 years

Combatting infection in LVAD patients - an outstanding talk by @AnnWoolleyMD @ISHLT #ISHLT2024

1

2

41

Clinical Infectious Diseases

@CIDJournal

2 years

Recommendations detailing a standardized approach for using PET/CT and SPECT/CT imaging to improve the evaluation and subsequent outcomes of patients with cardiovascular infection. ✅ Just Accepted 🆓 Freely Available https://t.co/SG1YbpvDsv

academic.oup.com

Abstract. This document on cardiovascular infection, including infective endocarditis, is the first in the American Society of Nuclear Cardiology Imaging I

0

10

35

Abhay Dhand

@DhandAbhay

2 years

@AnnWoolleyMD giving Transplant Grand Rounds @WestchesterMed/@nymedcollege. Looking forward to learning her expertise in expanding the donor pool and managing donor derived infections in transplant recipients.

1

7

American Society of Transplantation (AST)

@AST_info

2 years

Thank you @RepJerryNadler, for your unwavering support of living donors!

Rep. Nadler

@RepJerryNadler

2 years

Today, I met with doctors and advocates with @AST_info on the importance of passing my bill, the #LivingDonorProtectionAct. I commend the work that they are doing to promote #LivingDonors which will reduce waiting lists and preserve health quality.

1

4

22

Paul Sax

@PaulSaxMD

2 years

Remarkable RCT from Norway demonstrating that starting HCV treatment in the hospital with newly diagnosed HCV among PWIDs is superior to deferring therapy to outpatient care in achieving HCV cure. Results argue for broader use. @HMidgard @selihep

academic.oup.com

Opportunistic HCV treatment among hospitalized people who inject drugs was superior to a referral-based standard of care in terms of treatment initiation a

4

94

230

STAT

@statnews

2 years

We decided to put #ChatGPT to the test at #STATSummit last week, pitting the tool against infectious disease specialist @AnnWoolleyMD. Watch the video to see what happened:

0

1

3

Annalisa Merelli

@missanabeem

2 years

Also in the doctor vs robot (chatgpt) session, love hearing @AnnWoolleyMD (the doctor!) for through her thinking to diagnose the patient, which she continues to do more accurately than the bot. #STATSummit

0

3

8

Ann Woolley

@AnnWoolleyMD

2 years

Thanks @syshaw for the nice comment. It was a fun session to do with @MarcSucciMD @bwh_id @mgh_id @statnews

Stanley Y Shaw

@syshaw

2 years

Fascinating session! ChatGPT seemed like an eager med student, with its overly complete, less focused differential dx & work up. People should watch @AnnWoolleyMD describe her thought processes on video - there’s a special elegance when an experienced ID doc synthesizes a case!

1

0

10

Ann Woolley

@AnnWoolleyMD

2 years

Couldn’t agree more @MichaelGIsonMD @EmilyBlumbergMD gave an excellent talk! Congratulations on this honor and and all you’ve done for transplant ID!

Michael Ison, MD MS

@MichaelGIsonMD

2 years

excited to see @EmilyBlumbergMD, @IDSAInfo Finland Lecturer for 2023, shining a light on #TxID - highlighting about our key role in expanding the donor pool. Given all that Emily has done & how many stars she’s trained - I cannot think of a more deserving awardee!

0

8

Joanna Schaenman MD PhD

@jschaenman

2 years

Wonderful to focus on Transplant ID at #IDWeek2023 featuring one of our best and brightest in the field to give the Max Finland lecture today- exciting to see a familiar face on the official app !! @EmilyBlumbergMD @AST_IDCOP @IDSAInfo

1

2

25